The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products
Status:
Withdrawn
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Single-center open-label multiple dose randomized two period cross-over study to examine
Advanced Glycation End Product (AGE) levels in human subjects pre and post empagliflozin
administration.